Techniques for Detection of Minimal Residual Disease

References

• Cheson H. D., Cassileth P. A., Head D. R., Schiffer C. A., Bennet J. M., Bloomfield C. D., Brunning R., Gale R. P., Grever M. R., Keating M. J., Sawitsky A., Stass S., Weinstein H., Woods W. G. Report of the National cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin Oncol. 1990; 8: 813–818
   PubMed Web of Science ®Google Scholar
• Martens A. C. M., van Bekkum D. W., Hegenbeek A. The BN acute myelocytic leukemia (BNML) (A rat model for studying human acute myelocytic leukemia (AML)). Leukemia 1990; 4: 241–257
   PubMed Web of Science ®Google Scholar
• Schultz F. W., Martens A. C. M., Hagenheek A. The contribution of residual leukemic cells in the graft to leukemia relapse after autologous hone marrow transplantation: mathematical considerations. Leukemia 1989; 3: 530–534
   PubMed Web of Science ®Google Scholar
• Appelbaum F. R. Marrow transplantation for hematologic malignanices: a brief review of current status and future prospects. Semin. Hematol. 1988; 25: 16–22, Suppl. 3
   PubMed Web of Science ®Google Scholar
• Advisory Committee of the International Autologous Bone Marrow Transplant Registry., Autologous Bone Marrow Transplant. Different indications in Europe and North America. Lancet 1989; 11: 317–318
   Google Scholar
• Rizzoli V., Mangoni L. Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. Bone Marrow Purging and Processing, S. R. Gross, A. P. Gee, D. A. Worthington, DA White. Alan Liss, New York 1990; 21–38
   Google Scholar
• Hagenbeek A., Martens A. C. M. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells. Leukemia 1989; 3: 535–537
   PubMed Web of Science ®Google Scholar
• Slavin S., Ackerstein A., Naparstek E., Or R., Weiss L. The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?. Bone, Marrow Transplant 1990; 6: 155–161
   PubMed Web of Science ®Google Scholar
• Brenner M. K., Rill D. R., Moen R. C., Krance R. A., Mirro J., Jr., Anderson W. F., Ihle J. N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85–86
   PubMed Web of Science ®Google Scholar
• Campana D., Coustan-Smith E., Behm F. G. The definition of remission in acute leukemia with immunologic techniques. Hone Marrow Transplant 1991; 8: 429–437
   PubMed Web of Science ®Google Scholar
• Rabbitts T. H. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641–644
   PubMed Web of Science ®Google Scholar
• Wormann B. Implications of detection of minimal residual disease. Current Opinion Oncol. 1993; 5: 3–12
   PubMedGoogle Scholar
• Cuneo A., Wlodarska I., Aly M. S., Piva N., Carli M. G., Fagioli F., Tallarico A., Pazzi I., Ferrari L., Cassiman J. J., Berghe H Van Den, Castoldi G. L. Non-radioactive in situ hybridization for the detection of trisomy 12 in B-cell chronic lymphocytic leukaemia. Br. J. Haematol. 1992; 81: 192–196
   PubMed Web of Science ®Google Scholar
• Campana D., Coustan-Smith E., Janossy G. The immunologic detection of MRD in acute leukemia. Blood 1990; 76: 163–171
   PubMed Web of Science ®Google Scholar
• van Dongen J. J. M. Human T cell differentiation: basic aspects and their clinical applications. Ph D Thesis, Erasmus University, RotterdamThe Netherlands 1990
   Google Scholar
• Terstappen L. W. M. M., Safford M., Konemann S., Loken M. R., Zurlutter K., Buchner T. H., Hiddemann S., Wormann B. Flow cytometric characterization of acute myeloid leukemia: II. Extreme heterogeneity at diagnosis. Leukemia 1991; 5: 757–767
   Web of Science ®Google Scholar
• Negrin R. S., Blume K. G. The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 1991; 78: 255–258
   PubMed Web of Science ®Google Scholar
• van Dongen J. J. M., Breit T. M., Adriaansen H. J., Beishuizen A., Hooijkaaa H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6: 47–59, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Yamada M., Hudson S., Tornay O., Rovera G. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementary-determining region (CDR-III) specific probes. Proc Natl. Acad. Sci. USA 1989; 86: 5123–5127
   PubMed Web of Science ®Google Scholar
• Taylor J. J., Rowe D., Williamson I. K., Christmas S. E., Proctor S. J., Middleton P. G. Detection of T-cell receptor gamma chain V gene rearrangements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia. Blood 1991; 77: 1989–1995
   PubMed Web of Science ®Google Scholar
• Hansen-Hagge T. E., Yokota S., Bartram C. R. Detection of MRD in acute lymphoblastic leukemia by in vitro amplification of rearranged T cell receptor delta chain sequences. Blood 1989; 76: 1762–1767
   Google Scholar
• Billadeau D., Blackstadt M., Greipp P., Kyle R. A., Oken M. M., Kay N., van Ness B. Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood 1991; 78: 3021–3029
   PubMed Web of Science ®Google Scholar
• Cross N. C. P., Feng L., Chase A., Bungey J., Hughes T. P., Goldman J. M. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcript in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929–1936
   PubMed Web of Science ®Google Scholar
• Neale G. A. M., Menarguez J., Kitchingman G. R., Fitzgerald T. J., Koehler M., Mirro J., Jr., Goorha R. M. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse. Blood 1991; 78: 739–747
   PubMed Web of Science ®Google Scholar
• Vincent P. C., Sutherland R., Bradley M., Lind D., Gunz F. Marrow culture studies in adult acute leukemia at presentation and during remission. Blood 1977; 8: 903–909
   Google Scholar
• Curtis J. E., Cowan D. H., Bergsagel D. E., Hasselback R., McCulloch E. A. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell culture criteria. Can. Cancer Med. Assoc. J. 1975; 113: 289–297
   PubMed Web of Science ®Google Scholar
• Estrov Z., Grunberger T., Dubé I. D., Wang Y. P., Freedman M. H. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission. N. Engl. J. Med., 315: 538–542
   PubMed Web of Science ®Google Scholar
• Miller C. B., Zehnbauer B. A., Piantadosi S., Rowley S. D., Jones R. J. Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation. Blood, 78: 1125–1131
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Mangoni L., Piovani G., Garau D., Almici C., Rizzoli V. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood 1994; 83: 1373–1380
   PubMed Web of Science ®Google Scholar